Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

Paul G. Richardson; Fredrik Schjesvold; Katja Weisel; Philippe Moreau; Larry D. Anderson; Darrell White; Paula Rodriguez-Otero; Pieter Sonneveld; Monika Engelhardt; Matthew Jenner; Alessandro Corso; Jan Dürig; Michel Pavic; Morten Salomo; Meral Beksac; Albert Oriol; Jindriska Lindsay; Anna Marina Liberati; Monica Galli; Pawel Robak; Alessandra Larocca; Munci Yagci; Filiz Vural; Abraham S. Kanate; Ruiyun Jiang; Lara Grote; Teresa Peluso; Meletios Dimopoulos

doi:10.1111/ejh.13706

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

Paul G. Richardson, Fredrik Schjesvold, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Paula Rodriguez-Otero, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Meral Beksac, Albert Oriol, Jindriska Lindsay, Anna Marina Liberati, Monica Galli, Pawel RobakAlessandra Larocca, Munci Yagci, Filiz Vural, Abraham S. Kanate, Ruiyun Jiang, Lara Grote, Teresa Peluso, Meletios Dimopoulos

科研成果: 期刊稿件 › 文章 › 同行评审

11 引用（Scopus）

源语言	英语
页（从-至）	73-83
页数	11
期刊	European Journal of Haematology
卷	108
期	1
DOI	https://doi.org/10.1111/ejh.13706
出版状态	已出版 - 1月 2022
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学

访问文件

10.1111/ejh.13706

其它文件与链接

引用此

Richardson, P. G., Schjesvold, F., Weisel, K., Moreau, P., Anderson, L. D., White, D., Rodriguez-Otero, P., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Beksac, M., Oriol, A., Lindsay, J., Liberati, A. M., Galli, M., ... Dimopoulos, M. (2022). Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. European Journal of Haematology, 108(1), 73-83. https://doi.org/10.1111/ejh.13706

Richardson, PG, Schjesvold, F, Weisel, K, Moreau, P, Anderson, LD, White, D, Rodriguez-Otero, P, Sonneveld, P, Engelhardt, M, Jenner, M, Corso, A, Dürig, J, Pavic, M, Salomo, M, Beksac, M, Oriol, A, Lindsay, J, Liberati, AM, Galli, M, Robak, P, Larocca, A, Yagci, M, Vural, F, Kanate, AS, Jiang, R, Grote, L, Peluso, T & Dimopoulos, M 2022, 'Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics', European Journal of Haematology, 卷 108, 号码 1, 页码 73-83. https://doi.org/10.1111/ejh.13706

@article{51aab74fa61342cda8b23411aee9866d,

title = "Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics",

keywords = "aged, chromosome aberrations, multiple myeloma, pomalidomide, renal insufficiency",

author = "Richardson, {Paul G.} and Fredrik Schjesvold and Katja Weisel and Philippe Moreau and Anderson, {Larry D.} and Darrell White and Paula Rodriguez-Otero and Pieter Sonneveld and Monika Engelhardt and Matthew Jenner and Alessandro Corso and Jan D{\"u}rig and Michel Pavic and Morten Salomo and Meral Beksac and Albert Oriol and Jindriska Lindsay and Liberati, {Anna Marina} and Monica Galli and Pawel Robak and Alessandra Larocca and Munci Yagci and Filiz Vural and Kanate, {Abraham S.} and Ruiyun Jiang and Lara Grote and Teresa Peluso and Meletios Dimopoulos",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.",

year = "2022",

month = jan,

doi = "10.1111/ejh.13706",

language = "English",

volume = "108",

pages = "73--83",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma

T2 - A subanalysis of OPTIMISMM by clinical characteristics

AU - Richardson, Paul G.

AU - Schjesvold, Fredrik

AU - Weisel, Katja

AU - Moreau, Philippe

AU - Anderson, Larry D.

AU - White, Darrell

AU - Rodriguez-Otero, Paula

AU - Sonneveld, Pieter

AU - Engelhardt, Monika

AU - Jenner, Matthew

AU - Corso, Alessandro

AU - Dürig, Jan

AU - Pavic, Michel

AU - Salomo, Morten

AU - Beksac, Meral

AU - Oriol, Albert

AU - Lindsay, Jindriska

AU - Liberati, Anna Marina

AU - Galli, Monica

AU - Robak, Pawel

AU - Larocca, Alessandra

AU - Yagci, Munci

AU - Vural, Filiz

AU - Kanate, Abraham S.

AU - Jiang, Ruiyun

AU - Grote, Lara

AU - Peluso, Teresa

AU - Dimopoulos, Meletios

PY - 2022/1

Y1 - 2022/1

KW - aged

KW - chromosome aberrations

KW - multiple myeloma

KW - pomalidomide

KW - renal insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85115264782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115264782&partnerID=8YFLogxK

U2 - 10.1111/ejh.13706

DO - 10.1111/ejh.13706

M3 - Article

C2 - 34496096

AN - SCOPUS:85115264782

SN - 0902-4441

VL - 108

SP - 73

EP - 83

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 1

ER -

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此